| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/14/2004 | US6790847 Topical application of cetirizine and loratadine |
| 09/14/2004 | US6790842 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS |
| 09/14/2004 | US6790830 Use of 3-position cyclosporin derivatives for hair growth |
| 09/14/2004 | US6790827 Bioconjugates and delivery of bioactive agents |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | US6790434 Sunscreen agents; mixture of deactivated bacteria and plant extract |
| 09/14/2004 | CA2315826C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 09/10/2004 | WO2004076620A2 Human antibodies specific for interleukin 15 (il-15) |
| 09/10/2004 | WO2004076476A1 Glycopeptide and use thereof as proteoglycan initiator |
| 09/10/2004 | WO2004076458A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | WO2004076418A1 Ligands that modulate lxr-type receptors |
| 09/10/2004 | WO2004075917A1 Organ or tissue fibrosis inhibitor |
| 09/10/2004 | WO2004075915A1 Remedies for allergic contact dermatitis |
| 09/10/2004 | WO2004075914A1 Methods for promoting wound healing and/or reducing scar formation |
| 09/10/2004 | WO2004075910A1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 09/10/2004 | WO2004075906A1 Antiinflammtory agent and antiinflammatory medical material |
| 09/10/2004 | WO2004075902A1 Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder |
| 09/10/2004 | WO2004075890A1 Medicinal composition containing stabilized imidazole derivative and method of stabilizing imidazole derivative |
| 09/10/2004 | WO2004075867A2 Preparations containing an extract of eperua falcata and/or constituents of the latter |
| 09/10/2004 | WO2004075849A2 Method and composition for treating hypopigmentation of the hair and skin |
| 09/10/2004 | WO2004075821A2 Cosmetic use of inositol |
| 09/10/2004 | WO2004075816A2 Method for the production of flavonoid-containing compositions and use thereof |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004039409A3 Composition comprising activators of ik potassium channels and calcineurin antagonists and use thereof |
| 09/10/2004 | WO2004014352A3 Methods for treating carbonic anhydrase mediated disorders |
| 09/10/2004 | WO2003090671A3 Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance |
| 09/10/2004 | WO2003070897A3 RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR SUPERFAMILY GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | WO2003030816A3 Combinatorial anti-acne compositions |
| 09/10/2004 | WO2003007871A3 Process for the preparation of acitretin |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | CA2516824A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/10/2004 | CA2516378A1 Human antibodies specific for interleukin 15 (il-15) |
| 09/10/2004 | CA2512886A1 Ligands that modulate lxr-type receptors |
| 09/09/2004 | US20040176601 Benzimisazo[4,5-f]isoquinolinone derivatives |
| 09/09/2004 | US20040176456 Method of treatment for sexual dysfunction |
| 09/09/2004 | US20040176448 Use of carnitine and/or one or more acyl-carnitines for producing cosmetic or dermatological preparations, which increase ceramide biosynthesis |
| 09/09/2004 | US20040176443 Capsaicin receptor ligands |
| 09/09/2004 | US20040176434 Pyrazoloanthrone derivatives as Jun N-terminal kinase inhibitors; diabetes; obesity |
| 09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 09/09/2004 | US20040176421 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis |
| 09/09/2004 | US20040176417 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 09/09/2004 | US20040176411 especially useful for treating asthma and/or rhinitis; example compound N-[[[2-[4-(3,4-dichlorophenoxy)-1-piperidinyl]ethyl]amino]carbonyl]-4-methyl-benzenesulfonamide |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176386 Compounds |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176365 1,8-Naphthyridin-2(1H)-one derivatives; antiasthmatic, antihistamine, and bronchodilator agents; nontoxic, side effect reduction |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | US20040176342 Fluticasone lotion having improved vasoconstrictor activity |
| 09/09/2004 | US20040176324 Derivatives of 4,7-ethanothiopyrano[3,4-c]pyrrole-1,3-(2H)-dione, 4,7-epoxy-1H-isoindole-1,3(2H)-dione, and/or 4,7-ethano-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione derivatives; autoimmune diseases; anticarcinogenic agents |
| 09/09/2004 | US20040176320 Use of at least one glycoinhibitor substance |
| 09/09/2004 | US20040176319 Cellular uptake of bioactive agents |
| 09/09/2004 | US20040176288 Treatment and composition for wound healing |
| 09/09/2004 | US20040176286 Use of agt and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/09/2004 | US20040176252 Well tolerated; intracellularly increasing cAMP; antiasthmatics, antiinflammatories: regulation of eosinophiles activation and degranulation |
| 09/09/2004 | US20040175767 for lightening or darkening the pigmentation of cells and tissue (skin) in cells/cell-free systems; for drug screening |
| 09/09/2004 | US20040175433 using a viscous rather than a liquid footbath performs much better in preventing and combating hoof diseases; active ingredient and a colloid former |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175400 Reducing secretions from the meibomian glands; vision defects |
| 09/09/2004 | US20040175397 Citrullinylarginine dipeptide analogs and their dermatological uses as care and treatment agents |
| 09/09/2004 | US20040175386 Composite powders and skin preparations for external use containing the same |
| 09/09/2004 | US20040175378 Monoclonal antibody 3G4, or an antigen-binding region or immunoconjugate thereof, produced by hybridoma ATCC PTA 4545; binds to phosphatidyl serine |
| 09/09/2004 | US20040175353 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damage cutaneous tissue |
| 09/09/2004 | US20040175349 Method of inhibiting hair growth |
| 09/09/2004 | US20040175342 Process of making and using composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer |
| 09/09/2004 | US20040175337 Photoprotective cosmetic compositions containing aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile and novel aromatic amide, sulphonamide or carbamate derivatives of acrylonitrile |
| 09/09/2004 | US20040175335 Sunscreen composition |
| 09/09/2004 | DE10308162A1 Verfahren zur Herstellung von Flavonoid-haltigen Zusammensetzungen und ihre Verwendung Process for the preparation of flavonoid-containing compositions and their use |
| 09/08/2004 | EP1454950A1 Pullulan-containing powder, process for producing the same and use thereof |
| 09/08/2004 | EP1454907A1 Quninazoline and pyridopyrmidine derivatives |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1454897A1 PYRAZOLOPYRIMIDINONE DERIVATIVES HAVING PDE7−INHIBITORY ACTIVITY |
| 09/08/2004 | EP1454633A1 Cosmetic or pharmaceutical composition for topical use to prevent or treat androgenetic alopecia |
| 09/08/2004 | EP1453962A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453844A2 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 09/08/2004 | EP1453832A1 Ring fused pyrazole derivatives |
| 09/08/2004 | EP1453829A1 Sulfonamido substituted imidazopyridines |
| 09/08/2004 | EP1453820A1 Substituted 6h-dibenzo c,h]chromenes as estrogenic agents |
| 09/08/2004 | EP1453804A2 Ccr-3 receptor antagonists vii |
| 09/08/2004 | EP1453798A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2004 | EP1453795A2 Esters and amides as ppar-alpha agonists |
| 09/08/2004 | EP1453782A2 Substituted phenyl naphthalenes as estrogenic agents |
| 09/08/2004 | EP1453777A1 Functionalized higher diamondoids |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453539A2 Immunotherapeutic methods and systems |
| 09/08/2004 | EP1453526A2 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
| 09/08/2004 | EP1453507A2 Solubilized topoisomerase poison agents |
| 09/08/2004 | EP1453448A1 Oxygen producing device for woundcare |
| 09/08/2004 | EP1453431A2 Method and apparatus for the stimulation of hair growth |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1289950B1 Serine protease inhibitors |
| 09/08/2004 | EP1235571B1 Use of melatonin for treating androgenetic and diffuse female type alopecia |
| 09/08/2004 | EP1231931B1 Methods of treating inflammatory bowel disease using cholera toxin b subunit |
| 09/08/2004 | EP1189579B1 Gelled aqueous cosmetic compositions |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP1039874B1 Compositions and methods for treatment of alopecia |